The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Capsaicin: The biggest winner in CAM for 2009

    FDAQutenza (capsaicin) 8% patch is a medicated skin patch that can be used to help relieve the pain of post-herpetic neuralgia (PHN).

    This high concentration is now approved by the FDA for use as a prescription drug. And that places this complementary option for treating PHN squarely in the main stream.

    Qutenza contains capsaicin, a compound found in chili peppers. Although there are over-the-counter products with lower concentrations of capsaicin that are marketed for the treatment of PHN, Qutenza is the first pure, concentrated, synthetic capsaicin-containing prescription drug to undergo FDA review.

    The most frequently reported adverse drug reactions included pain, swelling, itching, redness, and bumps at the application site.

    The bottom line?
    Qutenza must be applied to the skin by a healthcare professional since placement of the patch can be quite painful, requiring the use of a local topical anesthetic, as well as additional pain relief such as ice or use of opioid pain relievers.

    The patient must also be monitored for at least an hour since there is a risk of a significant rise in blood pressure following patch placement.

    11/19/09 20:05 JR

    Leave a Comment

    You must be logged in to post a comment.